330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies
oleh: Mohammad Zaidi, Yuchen Zhang, Kavita Dhodapkar, Madhav Dhodapkar, Gregory Lesinski, Matthew Farren, Christina Wu, Rafi Ahmed, Cameron Herting, Deon Doxie, Michael Ware, Olatunji Alese, Walid Shaib, Mehmet Akce, Amanda Ruggieri, Juan Sarmiento, Shishir Maithel, Bassel El-rayes
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.